HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Donor human milk versus formula for preventing necrotising enterocolitis in preterm infants: systematic review.

AbstractOBJECTIVES:
To determine if enteral feeding with donor human milk compared with formula milk reduces the incidence of necrotising enterocolitis (NEC) in preterm or low birthweight infants.
METHODS:
Systematic review and meta-analysis of randomised controlled trials.
RESULTS:
Four small trials, all initiated more than 20 years ago, fulfilled the prespecified inclusion criteria. None of the trials individually found any statistically significant difference in the incidence of NEC. However, meta-analysis found that feeding with donor human milk was associated with a significantly reduced relative risk (RR) of NEC. Infants who received donor human milk were three times less likely to develop NEC (RR 0.34; 95% confidence interval (CI) 0.12 to 0.99), and four times less likely to have confirmed NEC (RR 0.25; 95% CI 0.06 to 0.98) than infants who received formula milk.
CONCLUSIONS:
It may be appropriate to consider further larger trials to compare growth, development, and the incidence of adverse outcomes, including NEC, in preterm infants who receive donor human milk versus formula milk.
AuthorsW McGuire, M Y Anthony
JournalArchives of disease in childhood. Fetal and neonatal edition (Arch Dis Child Fetal Neonatal Ed) Vol. 88 Issue 1 Pg. F11-4 (Jan 2003) ISSN: 1359-2998 [Print] England
PMID12496220 (Publication Type: Comparative Study, Journal Article, Meta-Analysis, Review, Systematic Review)
Topics
  • Bottle Feeding
  • Enteral Nutrition (methods)
  • Enterocolitis, Necrotizing (prevention & control)
  • Humans
  • Infant
  • Infant Nutritional Physiological Phenomena
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases (prevention & control)
  • Milk Banks
  • Milk, Human
  • Randomized Controlled Trials as Topic
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: